CAPSULE
Background:uPAR is a multifunctional protein, overexpressed in all human cancers. Results: uPAR overexpression with radiation enhances β-catenin stabilization, β-catenin gene transcription and Wnt-7a-β-catenin-Tcf/Lefmediated transactivation. Conclusion:Association of uPAR with β-catenin and various transcription factors involved in embryonic development suggests that uPAR is a potent activator of cancer stemness. Significance:Targeting uPAR in cancer patients undergoing radiotherapy will have favorable therapeutic implications. SUMMARY Urokinase plasminogen activator receptor (uPAR) is known to promote invasion, migration and metastasis in cancer cells. In this report, we showed that ionizing radiation (IR)-induced uPAR has a role in Wnt-β-catenin signaling and mediates induction of cancer stem cell (CSC)-like properties in medulloblastoma cell lines UW228 and D283. We observed that IR induced the expression of uPAR, CSC markers such as Musashi-1 and CD44 and activated Wnt-7a-β-catenin signaling molecules. Overexpression of uPAR alone or with IR treatment led to increased WNT-7a-β-cateninTcf/Lef-mediated transactivation, thereby promoting cancer stemness. In contrast, treatment with shRNA specific for uPAR (pU) suppressed Wnt-7a-β-catenin-Tcf/Lef-mediated transactivation both in vitro and in vivo. Quercetin, a potent Wnt/β-catenin inhibitor suppressed uPAR and uPAR-mediated Wnt/β-catenin activation and further, addition of recombinant human Wnt-7a protein induced uPAR, indicating existence of a mutual regulatory relationship between uPAR and Wnt/β-catenin signaling. We showed that uPAR was physically associated with Wnt effector molecule β-catenin on the membrane, cytoplasm and nucleus of IR-treated cells and CSC. Most interestingly, we demonstrated for the first time that localization of uPAR in nucleus was associated with transcription factors (TF) and their specific response elements. We observed from uPAR-ChIP, TF protein and protein/DNA array analyses that uPAR associates with activating enhancer binding protein 2 alpha (AP2a) and mediates β-catenin gene transcription.
Moreover, association of uPAR with β-cateninTcf/Lef complex and various other TF involved during embryonic development and cancer indicates that uPAR is a potent activator of stemness and targeting of uPAR in combination with radiation has significant therapeutic implications.
INTRODUCTION
Medulloblastoma accounts for 15% of all brain tumors in children (1) . Treatment of medulloblastoma includes surgery, radiation therapy and chemotherapy. Despite improved radiation therapy techniques, 50% of medulloblastomas are known to recur (1, 2) . Reduced radiation dose in combination with molecular targeted therapy, is now being studied as an alternative to traditional approaches. Urokinase-type plasminogen activator (uPAR) is overexpressed in tumor-stromal invasive microenvironment in many human cancers (3, 4) . Role of uPAR in tumor progression and angiogenesis is well characterized (5) (6) (7) . Targeting uPAR has shown a promising anti-tumor effect in treatment of uPAR-overexpressing tumors (8, 9) . Most recently, uPAR has been shown to be overexpressed after IR treatment and its suppression caused reduced invasion and migration in medulloblastoma cells (10) . uPAR overexpression in human breast cancer cells was shown to promote cancer stem cell (CSC)-like properties which include increased expression of CD44, β1/CD29 and α6/CD49f molecules (11) . Thus relevance of uPAR at facilitating the development of CSC is very evident and needs to be studied further. Medulloblastoma, also known as primitive neuroectodermal tumors (PNET) have aberrant activation of developmental signaling pathways such as Wnt, Shh and Notch (12, 13) . Activation of Wnt signaling pathway has been reported in 25% of sporadic medulloblastomas, and these include 15% of cases with mutations in CTNNB1 (encoding β-catenin), APC and Axin1 (14) . Our present study on medulloblastoma stem cells links overexpression of uPAR with activation of Wnt/β-catenin signaling, which is enhanced upon radiation treatment. Canonical Wnt signaling pathway is a critical regulator of stem cell signaling through key molecules such as β-catenin and T-cell factor/lymphoid enhancer factor (Tcf/Lef) family of transcription factors (15) . This β-catenin-Tcf/Lef complex in nucleus is known to increase transcription of proto-oncogenes such as c-myc, MMPs, c-jun, fra-1 and uPAR (16) and thereby, indicating that a possible crosstalk exists between uPAR and β-catenin signaling pathway. Jankun et al., (17) showed localization of uPAR on cell surface and in nucleus of breast cancer cells. Later, Dumler et al., (18) demonstrated cointernalization of uPAR-nucleolin complex inside the cell, which emphasizes the possibility of nuclear translocation of uPAR. We showed that IR-induced overexpression of uPAR leads to uPAR translocation in nucleus and its association with different transcription factors that may facilitate maintenance of stemness. Further, our studies explored the role of uPAR and its association with Wnt/β-catenin signaling in medulloblastoma stem cells upon IR treatment.
EXPERIMENTAL PROCEDURES
Cell lines, cancer stem cell (CSC) neurospheres, spheroids, transfection and radiation The early-passage culture of human medulloblastoma cell lines UW228 (a kind gift from Dr. Francis Ali-Osman) and D283 Med (ATCC #HTB 185) were maintained in RPMI and Advanced-MEM respectively (19) . Cancer stem cell (CSC) neurospheres were obtained from parental UW228 and D283 cells as described previously (20) . Primary neurospheres were obtained in 5-6 days and were subsequently disturbed by trituration; single cell suspension obtained was then plated for secondary neurospheres formation. Neurospheres around 8-14 passages were used for present study. Neurospheres were examined for CSC-like properties by neurosphere formation assay. In a separate experiment spheroids were formed as described previously (21) . For combination treatments, a radiation dose of 6 Gy was given using RS 2000 Biological Irradiator X-ray unit (Rad Source Technologies Inc., Boca Raton, FL) (See Supplementary Methods). Plasmids, shRNA constructs, antibodies, inhibitor and reagents We used uPAR human cDNA cloned in pCMV6-AC vector (Origene, Rockville, MD) for fulllength uPAR (FL-uPAR) overexpression and uPAR overexpressing stable cells in our study are considered as Fl-uPAR cells. Vector alone (VA) was used as a control. Monocistronic-pU and bicistronic-pUM constructs designed to knockdown uPAR and MMP-9 were generated in our laboratory (22) . A pCDNA3-scrambled vector with an imperfect sequence (pSV) was used as a control. HSP90β (h) siRNA was purchased from Santa Cruz Biotechnology (Santa Cruz, CA). A cignal Tcf/Lef Reporter (luc) construct (CCS-018L) encoding firefly luciferase reporter gene along with a constitutively expressing renilla luciferase construct (40:1) (SABiosciences, Frederick, MD) were used to monitor Wnt signaling activity. Appropriate positive and negative control reporter plasmids were used, and all transfections were normalized to renilla luciferase activity. Quantification of both firefly and renilla luciferase reporters were done by using Dual-Luciferase® Reporter (DLR™) Assay system (Promega, Madison, WI). Relative luciferase units were measured in a luminometer (TD-20/20 DLReady) for cell suspension / Xenogen In Vivo Imaging System (Xenogen, Alameda, CA) for spheroids. Following antibodies: anti-uPAR, β-catenin, Tcf-1, Lef-1, Wnt-7a, Stro-1, Msi-1, CD44, pGSK3β  (Ser-9)  , HSP90β, CD133 and AP-2a were purchased from Santa Cruz Biotechnology (Santa Cruz, CA); p-β catenin (Ser33/37/Thr41) was purchased from Cell Signaling (Beverly, MA), and Wnt-1 was purchased from Abcam (Cambridge, MA). Recombinant human Wnt-7a protein was purchased from R & D systems (Minneapolis, MN), AP2 alpha protein was purchased from Novus Biologicals (Littleton, CO). Quercetin (100 µM) was purchased from Sigma (St. Louis, MO). Establishment of stable cells expressing Tcf/Lef GFP constructs D283 cells were transduced at 80% confluence in 6-well culture plates with Cignal Lenti Tcf/Lef Reporter (GFP) construct with VSV-g pseudotyped lentivirus particles expressing GFP gene under a minimal (m) CMV promoter and tandem repeats of TCF/LEF according to manufacture's guidelines (SA Biosciences). The medium was replaced with normal growth medium and incubated for 48 h. On day 3, cells were selected in 10 µg/ml puromycin containing medium. Around 13 puromycin-resistant single cell colonies were obtained with cloning rings and expanded. Clone with highest GFP expression was further maintained in the medium containing 2.5 µg/ml puromycin and was used for present study. D283-Tcf/Lef GFP stable cells were used to form self-renewing, free-floating neurospheres and were passaged every 8th day in 60 mm plates. Sub-cellular protein fractionation, western blotting, immuno precipitation and mass spectrometry Nuclear extracts and TritonX-114 mediated phase partitioning was performed according to standard protocol (19) . Immunoprecipitation (IP) assays were carried out by incubating 400 µg of nuclear/membrane/cytoplasmic extracts with specific primary antibody (2 µg) overnight at 4°C on an end-to-end rotator. Next, Catch and Release v2.0 IP kit (Millipore, Temecula CA) was used to immunoprecipitate and elute proteins in denaturing or non-denaturing buffers according to manufacturer's instructions. Immunoprecipitates were immunoblotted using specific primary antibodies. LC-MS/MS spectra analysis of immunoprecipitated membrane extract proteins of UW228 and D283 using anti-uPAR antibody was generated following standard protocol (see Supplementary Methods) (23) C with gentle shaking. Membranes were washed and incubated with anti-uPAR antibody for 2 h and subsequently, with secondary antibody for 1 h at RT. The spots were detected using chemiluminescence detection buffer. In a separate experiment, interaction of uPAR with TF binding oligonuclotide probes was shown using Protein/DNA array version I (Panomics). Nuclear extract from FL-uPARtransfected and IR-treated D283 cells were subjected to IP using anti-uPAR antibody and was eluted in non-denatured form. Eluted fraction (3 µg) was incubated with biotin labeled DNA binding Probes for 56 TFs (MA1210) to form protein/DNA complexes. Probes in the complexes were then extracted and hybridized to Protein/DNA array I and detected using HRPbased chemiluminescence detection buffer by following manufacturer's protocol. Binding of uPAR to TFs was observed as spots on X-ray film. Tcf/Lef and AP-2(1)-electrophoretic-mobility shift assays (EMSA) using 2 μg of nuclear extract was performed according to manufacturer's instructions (Panomics). Subcutaneous tumor (s.c.) growth We carried out s.c. implantation as previously described (24) . Tumor volume was calculated from formula 1/6 II (R max ) × (R min ) 2 , where R max and R min are maximum and minimum tumor radii, respectively. Surgical orthotopic implantation of D283 Tcf/Lef -GFP stable cell neurospheres Athymic nude mice at about three weeks of age were used for intracerebral injections. Mice were anesthetized using isoflurane gas anesthesia (~2%) and placed into stereotaxic frame (David Kopf Instruments, Tujunga, CA). A drill hole (0.5mm diameter) was created through skull and D283 Tcf/Lef-GFP neurospheres (1 × 10 5 cells/10 μl PBS), with or without IR treatment were implanted into the brain at a depth of 3 mm. Twelve days after tumor cell implantation, animals were randomized into four treatment groups as pSV, pSV+IR, pU and pU+IR (n=5). Each animal was treated intravenously with either pU or pSV (6-8 mg/kg body weight) plasmids on 12 th and 16 th day. Animals which lost ≥ 20% of body weight or had trouble ambulating or feeding were sacrificed. Animals were monitored for 45 days, which is when experiment was terminated. Mice brains were subjected to GFP imaging by stereo zoom dissection microscope (SZX12, Olympus, Melville, NY), before they were fixed in 10% buffered formalin and processed for paraffin embedding. Tissue sections (5 µm-thick) were obtained from paraffin blocks and stained with H&E using standard histological techniques.
Statistical analysis
All data are presented as means ± standard error (SE) of at least three independent experiments. One-way analysis of variance (ANOVA) combined with Tukey post-hoc test of means were used for multiple comparisons. Statistical differences are presented at p<0.05, p<0.01, and p<0.001.
RESULTS

Ionizing radiation (IR) induces uPAR overexpression and activation of Wnt/β-catenin signaling
We have previously described that IR treatment increases uPAR expression and activates uPAR dependent cell signaling (10) . Further, IR has been shown to induce radioresistance by aberrant activation of key stem cell pathways such as Wnt/β-catenin (25 1A) . Inactivation of GSK3β leads to β-catenin stabilization and activation of β-catenin-Tcf/Lef signaling (26) . To determine if IR-induced uPAR has a role in transcriptional activation of Wnt/β-catenin signaling necessary for CSC, we performed real time PCR in control, FL-uPAR, CSCs alone, and in combination with IR treatments. We observed that increased uPAR levels with IR treatment showed synergistic increase in mRNA transcript levels of  β-catenin, Tcf/Lef-1 and Wnt-7a in both UW228 and D283 cells (P<0.05). CSCs with IR treatment showed a prominent increase in expression levels of uPAR and Wnt molecules ( Fig. 1B & 1C) . We also observed a significant increase in mRNA transcript levels of GSK3β; however protein levels of GSK3β in immunoblot showed only a slight increase in IR-treated cells when compared to control cells. We used immuno-flow cytometry to examine whether uPAR overexpression with IR altered the abundance of Msi-1, whose expression is known to be regulated by Wnt pathway (27) . The levels of uPAR and Msi-1 were substantially increased in IR-treated UW228 and D283 cells and CSCs. uPAR overexpressing (Fl-uPAR) cells also showed increased levels of Msi-1 (Fig. 1D ). Moreover, both UW228 and D283 cells formed neurospheres with self-renewal capacity and we observed that the neurospheres forming ability of medulloblastoma cells were enhanced after IR treatment ( Supplementary Fig. 1 Fig. 2A & 2B) . Further, activation of Wnt/β-catenin signaling is known to increase transcription of uPAR and involves transcriptional activation of β-catenin (28) Thus, it is apparent that mutual regulatory mechanisms exist between uPAR and β-catenin signaling. In medulloblastoma cells, we found that addition of increasing concentrations of Wnt-7a protein (0, 50, 100, 200 ng/ml) induced β-catenin levels in whole cell lysates and nuclear-extracts ( Supplementary Fig. 1C ) and also enhanced the β-catenin-Tcf/Lef-mediated reporter activity ( Supplementary Fig. 1D ) in a dose-dependent manner. Wnt-7a protein at 200 ng concentration showed around 70% increase in nuclear translocation of β-catenin. Further, we observed that addition of Wnt-7a (200 ng/ml) alone or in combination with radiation showed increased β-catenin and uPAR expression (P<0.01) (Fig. 2C) . The p-β-catenin levels were decreased in Wnt-7a-treated cells. Wnt-7a immunoblot results of UW228 and D283 cells were similar to Fl-uPAR results as shown in Fig. 2A & 2B , which showed that both uPAR and Wnt-7a can mutually upregulate each other's expression. uPAR is associated with Wnt/β-catenin signaling Since uPAR is one of the transcriptional targets of β-catenin-Tcf/Lef signaling (29), we performed immunocytochemistry analysis in cancer cells and CSCs to study their association (Fig. 3A &  Supplementary Fig. 2C ). We observed that levels of uPAR and β-catenin were abundant in the membrane, cytoplasm and nucleus of IR-treated cells and CSCs, when compared to controls. Interestingly in control cells, we observed colocalization of uPAR with β-catenin on membrane (Fig. 3A-lane 1&3) , whereas in IR-treated cells we observed increased association of uPAR and  β-catenin which was more prominent in the nucleus (Fig. 3A-lane 2&4) . To confirm the above results, we performed immunoprecipitation (IP) studies using cellular extracts of UW228 and D283 control and IR-treated cells. The IP of nuclear extracts (NE) using anti-uPAR and reverse pull down IP using anti-β-catenin antibody confirmed the association between uPAR and β-catenin in NE (Fig. 3B & Supplementary Fig. 2A ). From IP of membrane extracts (ME), we also confirmed the association of uPAR and β-catenin in ME (Fig.  3B) . Consistent with these results, uPAR was found to be co-localized with β-catenin in human medulloblastoma tumor tissue array (US Biomax, Rockville, MD) (Fig. 3D) . Furthermore, immunoblots from IP studies were re-probed using anti-Lef/Tcf antibodies, which detected that Lef/Tcf proteins were co-precipitated with uPAR in NE but not in ME (Fig. 3B) . Further, to examine the role of uPAR in β-cateninTcf/Lef-mediated transactivation activity we performed EMSA. We observed that IR treatment upregulated β-catenin-Tcf/Lef activity in UW228 and D283 cells. Incubation of IR-treated NE with anti-uPAR antibody induced a supershift in Lef/Tcf-DNA complex migration; however, we observed that not all the Lef/Tcf was bound to uPAR ( Fig. 3C & Supplementary Fig. 2B ). Moreover, mass-spectrometry analysis of a prominent 90 kDa protein band (corresponding to molecular weight of β-catenin) obtained by immunoprecipitating uPAR from ME of control and IR-treated UW228 and D283 cells identified heat-shock protein 90β (HSP90β) (Fig. 3E) . Since uPAR is devoid of transmembrane and cytoplasmic domain, we anticipated that association of uPAR with β-catenin would involve other interlinking molecules. Accordingly, our study further examined if HSP90β acted as an interlinking molecule between uPAR and β-catenin. Our subsequent IP of membrane and whole cell extracts using anti-HSP90β antibody indicated association of uPAR/β-catenin/HSP90β which was noticeably enhanced after IR treatment (Fig. 3F) . Furthermore, we examined HSP90β, uPAR and β-catenin expression levels in control, IR, FluPAR, pU, HSP90β-siRNA and Wnt-7a-treated cells. We found that following IR, uPARand Wnt-7a-overexpression treatments, increased expression of HSP90β protein and upregulated uPAR and β-catenin levels were shown. Conversely, pU and HSP90β-siRNA treatments showed downregulation of these proteins (Fig.  3G) . uPAR knockdown suppressed canonical Wnt pathway in vitro Western blot analyses of IR-treated UW228 and D283 CSCs showed increased levels of β-catenin in nuclear extracts (NE), uPAR, CD133 in cytoplasmic extracts (CE) and Wnt-7a in culture filtrates (CF), when compared to controls. Since recent studies showed MMP-9 as a key indicator of Wnt activation in embryonic neural stem cells (30), we checked the activity of MMP-9 using CF of CSCs. We observed increased MMP-9 activity after IR treatment, which was correlated to Wnt-7a expression in CF and β-catenin levels in NE (Fig.  4A & 4B) . Furthermore, to replicate a 3D model of an intracranial tumor, we developed spheroids of UW228 and D283 CSCs for our studies. To assess the activity of the Wnt pathway, spheroids were transfected with cignal Tcf/Lef reporter (luc) construct encoding firefly luciferase. Using Tcf/Lef reporter assay, we found that the sublethal doses of IR, induced Wnt pathway activation in both UW228 (Fig. 4A1) and D283 (Fig. 4B1) CSC spheroids. The 6 Gy radiation dose was determined to be appropriate for our studies in medulloblastoma cell lines as this dose showed increased transactivation of β-catenin-Tcf/Lef when compared to controls (P<0.01) (Fig. 4A &  4B) . Additionally, to examine whether uPAR signals through β-catenin, the spheroids were transfected using pU/pUM constructs, designed to knockdown uPAR and MMP-9, and also simultaneously with cignal Tcf/Lef reporter (luc) construct. The IR treatment increased spheroid migration (Fig. 4C &   4D ) and expression of migration-associated molecules such as β-catenin and uPAR as determined by RT-PCR analysis (Fig 4C2 & 4D2) . The pU and pUM treatments resulted in loose, poorly adherent and less invasive spheroids and suppressed Tcf/Lef reporter activity in IR-treated spheroids (Fig. 4C1 & 4D1) . The pU and pUM treatment also showed increased p-β-catenin and decreased nuclear translocation of β-cateninTcf/Lef proteins after IR treatment (P<0.05). Moreover, we observed lower MMP-9 and Wnt-7a levels after pU/pUM treatment of CSCs (Fig. 4E) . uPAR knockdown suppressed in vivo canonical Wnt pathway D283-Tcf/Lef GFP stable cells were enriched for CSCs by subjecting to neurospheres formation (Fig. 5A1) followed by IR treatment, after which neurospheres suspension was implanted in the nude mice cerebellum region. IR-treated D283-Tcf/Lef GFP stable cell neurospheres showed increased migration to parts of the cerebellar hemisphere. The pU and pU+IR treatment showed lower GFP expression and reduced migration, wherein GFP expression was restricted to the site of injection when compared to respective controls (Fig. 5A2) . Furthermore, IR-treated tumors showed lower tumor burden and scattered tumor presence with multiple tumor foci, when compared to non-IR treated tumors in H&E staining. In contrast, pUand pU+IR-treated mice failed to form aggressive tumors and showed decreased tumor burden ( Supplementary Fig. 3A lane 1) . We further performed DAB staining which confirmed increased β-catenin and uPAR expression in tumor regions. From DAB staining, we observed several brown spots of β-catenin and uPAR within the nucleus, which were more prominent in IR-treated tumors. The pU-and pU+IR-treated tumors showed low levels of β-catenin and its nuclear localization ( Supplementary Fig. 3A lanes 2&3) . Additionally, immunoflorescence studies using Alexa Fluor conjugated secondary antibody against uPAR (blue) and β-catenin (red) confirmed their association (pink) in in vivo tumors. In IRtreated tumors we observed increased uPAR and β-catenin levels which were spread throughout the tumor region. In both non-IR and IR-treated tumors, suppression of uPAR inhibited β-catenin expression (Fig. 5B ).
uPAR association with transcription factors (TF) and role of uPAR in AP-2a-mediated transcriptional activation of β-catenin
uPAR is well known in establishing multiple contacts with various membrane and cytoplasmic proteins (31). Since we observed nuclear localization of uPAR upon IR treatment, we further extended our study to examine the possible association of uPAR with various TF and their response elements. Chromatin uPAR immunoprecipitation (ChIP) DNA was isolated from UW228 and D283 control and IR-treated cells which were then cloned, sequenced and analyzed. ChIP analyses identified a number of short individual sequences and at least sixteen of twenty-nine sequences showed a consensus 48 bp sequence consisting of endogenous AP2a and E2F-1 binding regions (Fig. 6A) . Further, TranSignal TM TF protein arrays were used to show the protein-protein interactions between human recombinant uPAR (ruPAR), which was used as bait, with multiple TFs immobilized on the membranes. The ruPAR showed binding with various TF (Fig. 6B and Supplementary Table 2) . Next ruPAR and uPAR immunoprecipitated from nuclear extracts of FluPAR and IR-treated D283 cells were incubated with different TF binding oligonuclotide probe mix, and their interaction was examined using Protein/DNA array. The ruPAR (green spots) and nuclear uPAR (red spots) interaction results with TF response elements are represented as overlapping yellow spots in Fig. 6C and listed in Supplementary Table 3 . Consistent with ChIP analysis, the TF protein array and protein/DNA array also showed uPAR association with AP2a. Following this we confirmed interaction of uPAR with AP2a in control and IRtreated UW228 and D283 cells by immunoprecipitation analysis (Fig. 6D) . Most interestingly, we observed around 16 putative AP2 binding sites (32) in the promoter region of human β-catenin gene. A number of these AP2 sites have been shown to play a role in β-catenin expression (33, 34) . To investigate whether uPAR binding to β-catenin promoter was localized around these sites, we used UW228 and D283 ChIP DNA immunoprecipitated by anti-uPAR and anti-IgG antibody. ChIP was carried out by scanning the uPAR binding in the first 1.6 kb 5'-flanking region of human β-catenin gene (EMBL Accession No. X89448), using semi-quantitative RT-PCR with primers for regions (R) named 1, 2, 3, 4, 5 and 6. uPAR enrichment at R4 (P<0.01), which includes 6 putative AP2 binding sites, was greater than at other regions containing AP2 (R3, R5 and R6) or no AP2 (R1 and R2). The coefficient of uPAR interaction to different AP-2 binding regions in β-catenin promoter indicated that uPAR binds to β-catenin promoter in a region detected by the R4 primers (Fig. 6E) . To further show the mechanism of this regulation, we treated UW228 and D283 cells with increasing concentrations of AP-2a protein (0, 1 and 5 ug/ml) in combination with IR. Semi-quantitative RT-PCR analysis using cDNA of AP2a-treated cells showed increased mRNA levels of both β-catenin as well as uPAR (Fig. 6F) . These results confirmed previous studies (33, 35) , which showed that both uPAR and β-catenin gene promoters have functional AP2 binding sites. Further, in our studies a sequence of the GAPDH gene (36) , not regulated by AP2, was used as internal control. Further, to examine the role of uPAR in AP2-mediated transcriptional activation of β-catenin, we performed AP2 EMSA analysis using nuclear extracts (NE) of control, IR, vector alone (VA), FluPAR and pU treated cells. We observed that IR treatment and uPAR overexpression caused an increase in AP2 activity when compared to control and pU-treated cells (Fig. 6G) . Further, the sequence alignment analysis ( Supplementary Fig. 3C ) showed that the AP2 EMSA probe sequence showed significant homology with the putative AP2 binding site on R4 region of β-catenin promoter (Fig. 6E) .
DISCUSSION
The term PNET has been applied to medulloblastomas to reflect its embryonal nature and for its potential to differentiate into neuronal and glial cells (37) . A better understanding of molecular link between cerebellar development and embryonal brain tumor formation will aid in development of new and novel therapies targeting medulloblastoma. Mutations associated with nuclear translocation of β-catenin show a favorable clinical outcome in treatment of medulloblastomas (14, 38) . Earlier we correlated increased nuclear translocation of β-catenin with increased MMP-9 (matrix metallopeptidase-9) expression and further showed that uPAR was involved in signaling after IR treatment (10, 19) . In continuation with our previous study, we demonstrate here that aberrant activation of canonical Wnt signaling pathway in IR-treated medulloblastoma cells is associated with uPAR overexpression. Further, we observed a synergistic increase in the expression of CSC marker, Msi-1 (musashi-1) in response to uPAR overexpression. Msi-1 expression is known to be regulated by canonical Wnt pathway (27) . Literature has shown that both uPAR and MMP-9 are known targets of β-catenin-Tcf/Lef signaling pathway (16, 39) . In our studies, we observed that addition of exogenous Wnt-7a protein to medulloblastoma cells showed increased uPAR expression. Therefore, to understand the role of these molecules in relation to stemness, we studied their association with -catenin and showed that increased β-catenin expression and its nuclear translocation is associated with uPAR overexpression. Moreover, quercetin, a known inhibitor of Wnt signaling (40) suppressed uPAR and uPAR-mediated increase in Wnt signaling molecules. Furthermore, uPAR knockdown (pU) suppressed IR-induced Wnt/β-catenin signaling both in vitro and in vivo. Taken together, this study provides direct evidence that mutual regulation mechanisms exist among uPAR and β-catenin signaling and signals underlying different processes regulating cancer cell-stemness and adaptation to radiation treatment (Fig. 7) . Recent studies have also shown that downregulation of uPAR results in suppression of a number of β-catenin downstream targets which were identified by a two dimensional gel electrophoresis (41) . Thus β-catenin, which is at crossroads of several signaling pathways, appears to be associated with uPAR-mediated signaling. Our studies have shown for first time that uPAR is associated with β-catenin and this association is enhanced with IR treatment and, further, that IR-treated medulloblastoma cells and CSCs showed increased nuclear association of these molecules. Although uPAR has been implicated to exist in nucleus via its association with nucleolin (17) but the functional role of uPAR in nucleus is not clear. Furthermore, role of uPAR in angiogenesis, inflammation, wound repair and tumor progression/metastasis (42-45) is due to its ability to engage in multiple protein-protein interactions (46) (47) (48) (49) (50) . Since uPAR is devoid of transmembrane and cytoplasmic domain, we anticipated that association of uPAR with β-catenin would involve other interlinking molecules. To determine these associated molecules, we immunoprecipitated membrane-associated uPAR extracts and subjected them to mass spectrometry. We identified HSP90β as the prominent interacting molecule by mass spectrometry. HSP90 overexpression is known to contribute to tumor cell survival by stabilizing aberrant signaling proteins (51) including more than 100 transcription factors (TF) and is responsible for retrograde movement of protein complexes towards the nucleus (51, 52) . In adult Tcell leukemia/lymphoma cells, HSP90 inhibition retarded nuclear translocation of β-catenin (34), and indicated a possible interaction between HSP90 and β-catenin. Our subsequent immunoprecipitation results indicated that HSP90 was interlinked with both uPAR and -catenin proteins and together they formed a more stable uPAR/-catenin/HSP90complex upon IR treatment when compared to control cells. Furthermore, the inhibitors of HSP90 and Wnt signaling are suggested to have promising anticancer activity in cancer stem cells (53) . Interestingly, pU treatment suppressed HSP90levels and downregulated the Wnt--catenin-Tcf/Lef-mediated signaling. Until now uPAR has been studied as an invasion-, migration-and metastasis-promoting protein in existing cancers; however, function of uPAR as a promoter of stemness was recently demonstrated in breast cancer by Jo et al., (11) . Our studies show that uPAR interacts with AP2a (activating enhancer binding protein 2 alpha) and E2F-1 (E2F transcription factor) proteins and their respective consensus sequence from ChIP, TF protein array and protein/DNA array analysis. When ruPAR was used to study protein-protein interaction with known TFs, we also observed that uPAR bound specifically to CEBP (CCAAT/enhancer binding protein), CBF (core-binding factor), E2F-1 and RXR/D-1 (retinoid X receptor/down-regulator of transcription 1) conversely, when uPAR was immuno-precipitated from nuclear extracts only a few TFs showed unique interaction, which were not seen when ruPAR alone was used, probably indicating that whole molecule uPAR is capable of interactions that are modulated by other nuclear factors. Interestingly, interaction with AP-2, AP-1 (activator protein 1), FAST-1 (forkhead activin signal transducer-1), MEF-1 (myocyte-specific enhancer factor 1), Pbx-1 (pre-B-cell leukemia homeobox 1) and PPAR (peroxisome proliferatoractivated receptors) was observed when both ruPAR and nuclear uPAR were used. It is interesting to note that promoter region of uPAR possesses Sp1 (Specificity Protein 1), AP-1, AP-2 and NF-kB (nuclear factor-kappa B) TF binding sites (54) . Presence of AP-1 and AP-2 in uPAR promoter region and the ability of uPAR to interact with these TFs probably indicate that uPAR is capable of self regulation to a large extent and is capable of regulating other molecules as well. In our previous studies, we observed such a regulation and demonstrated that suppression of uPAR alone caused suppression of uPA expression (55) It is also interesting to note that AP-1 binding sites are present on Wnt promoter (56, 57) , thus indicating that both Wnt and uPAR probably regulate expression of each other to a certain extent and overexpression of uPAR would cause activation of Wnt signaling as observed in our results. Previous studies have also shown that β-catenin promoter possesses a number of highaffinity TF binding sites, including AP2, SP1, NFkB and EGR1 (32) suggesting that uPAR can also regulate β-catenin which was also seen in our results. From our studies of chromatin uPAR immunoprecipitation (ChIP), TF protein and protein/DNA array we confirmed that uPAR associates with transcription factor AP2a and enhances β-catenin gene transcription. Further, we also observed that uPAR overexpression promotes AP2 activity which could be one of the mechanisms of increased β-catenin expression. The presence of AP-1 and AP-2 binding regions seen in promoters of various molecules need not indicate that all may be regulated by uPAR. However, it is indeed interesting to note that overexpression of uPAR was sufficient to up regulate some of them including β-catenin. Studies indicate that uPAR is not required for development or fertility in mice (58) probably indicating that uPAR may have an acquired role in cancer stem cell maintenance. Taken together, our data shows that uPAR overexpression upregulated Wnt-β-catenin signaling by stabilization of β-catenin protein via HSP90 association, increased transcription of β-catenin gene and increased transcription of Wnt ligand genes such as Wnt-7a. All these mechanisms contribute to increased accumulation of nuclear β-catenin and consequently, to activation of Wnt target gene transcription. As a result, targeting uPAR in cancer patients showing the presence of cancer stem cells undergoing radiotherapy will have favorable therapeutic implications.
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Authors declare no conflict of interest exists with this manuscript. Supplementary Fig. 2C. (B) Immunoprecipitation (IP) was performed using anti-uPAR antibody and reverse pull down IP using anti- β-catenin antibody to show the association of uPAR with β-catenin/Tcf/Lef in the nuclear extracts (NE) of control and IRtreated UW228 and D283 cells. The IP using anti-uPAR antibody was performed to show the association of uPAR with β-catenin in the membrane extracts (ME) as described in Materials and Methods. IgG denotes the anti-IgG antibody control in the IP assays (C) EMSA was performed with 2 g of nuclear extract (NE) from treated cells. Lane 1 is for the Tcf/Lef probe in the absence of NE and antibody, lanes 2-3 show NE of control and IR-treated D283 cells respectively, in the presence of anti-uPAR antibody (uPAR Ab), lanes 4-5 show NE of control and IR-treated D283 cells, respectively, in the presence of IgG antibody (IgG). (D) Medulloblastoma brain tissue microarray, containing 20 cases of medulloblastoma of brain consisting of 60 cores. Tissue arrays were processed for immunohistochemistry using anti-uPAR (green) and anti-β-catenin (red) antibodies as described in Materials and Methods. Microscopic examination was done (Olympus BX61 Fluoview, Minneapolis, MN) at a 40 X magnification. (E) The LC-MS/MS spectra analysis of a 90 kDa band, immunoprecipitated from the membrane extracts (ME) of UW228 and D283 control and IR treated cells using anti-uPAR antibody identified HSP90β. (F) The IP using anti-HSP90 was performed with membrane extract (ME) and whole cell extracts (CE) of control and IR-treated UW228 and D283 cells and was immunoblotted against anti-uPAR, -catenin and HSP90  antibodies; IgG denotes the anti-IgG antibody control in the IP assays. (G) Immunoblot analysis of whole cell lysates from control, IR, FluPAR, pU, HSP90β-siRNA and Wnt-7a treated D283 cells. The blots were developed using antibodies specific for HSP90β, β-catenin and uPAR; GAPDH was used as the loading control. To determine the activation of Wnt/β-catenin in control and IR-treated UW228 and D283 CSCs, immunoblot analysis was done with antibodies specific for β-catenin, uPAR and Wnt-7a; Lamin B and GAPDH were used as a loading controls for nuclear extract (NE) and cytoplasmic extract (CE) respectively. (A-D) UW228 and D283 CSCs (3x10 4 ) were seeded in 96-well plates coated with 1% agarose and cultured on a shaker at 120 rpm for 24 h. After single spheroids formed, the spheroids were given either different doses of IR treatment (A1 & B1) or transfected with pSV/pU/pUM plasmids in combination with IR treatment (C & D). All the spheroids were simultaneously transfected with a Tcf/Lef Reporter (luc) construct as described in Material and Methods. After 16 h, spheroids were transferred to 24-well plates and were allowed to grow for 48 h. The migration distance was measured for UW228 cells. (A1, B1, C1 & D1) The activity of β-catenin/Tcf/Lef signaling was monitored in cultured spheroids using the Dual-Luciferase® Reporter (DLR™) assay system and was measured by Xenogen IVIS imaging and represented graphically in terms of relative luciferase units (RLU) of firefly/renilla luciferase. Positive in Fig. 4A1 and 4B1 represents the positive control. The positive control denotes the RLU of the cells that are transfected with a constitutively expressing firefly and renilla luciferase construct. The error bars represent mean +SD from three independent experiments (P<0.01). (C2 & D2) RNA was isolated from 3 representative spheroids of each treatment and subjected to RT-PCR analysis using primers specific for uPAR and β-catenin, GAPDH was used as the loading control. (E) To determine the activation of Wnt/β-catenin in pSV, pU and pUM transfected UW228 and D283 CSCs, immunoblot analysis was done with antibodies specific for β-catenin, Lef-1, Tcf-1, uPAR and p-β-catenin and Wnt-7a; Lamin B and GAPDH were used as a loading controls for nuclear extract (NE) and cytoplasmic extract (CE) respectively. Gelatin zymography was performed to determine MMP-9 activity in the culture filtrates (CF) as described in supplementary Methods. The intracerebral tumors were established by surgical orthotopic implantation of D283 Tcf/Lef -GFP stable cell neurospheres (D283Tcf/Lef-GFP neurosphres) in nude mice. The mice were given intravenous treatment of pU plasmids as described in the Materials and Methods. Mice brains were subjected to GFP imaging using stereo zoom dissection microscope (SZX12, Olympus, Melville, NY) before fixing in 10% buffered formalin and processed for paraffin embedding. (B) Brain tissue sections were subjected to immunohistochemistry analysis. Immunohistochemical comparison using red and blue Alexa Fluor conjugates for β-catenin and uPAR, respectively. (Nollet F et al., 1996) . Quantitative PCR amplicons covering R1, R2, R3, R4, R5 and R6 are indicated by black lines below. To investigate whether uPAR binding to the β-catenin promoter is localized around these sites, we used UW228 and D283 ChIP DNA immunoprecipitated by anti-uPAR and anti-IgG antibody. Immunoprecipitated DNA was analyzed by semi-quantitative RT-PCR using ChIP specific primers covering The ionizing radiation (IR) treatment induces uPAR expression and activates uPARdependent cell signaling. Further, IR has been shown to induce radioresistance by aberrant activation of key stem cell pathways such as Wnt/β-catenin signaling. The IR-induced activation of uPAR and Wnt/β-catenin signaling is mediated by increased stabilization of oncoproteins, uPAR and β-catenin by forming a complex with HSP90β protein. As a result, both uPAR and β-catenin are translocated to the nucleus. In contrast, treatment with shRNA specific for uPAR (pU) showed increased β-catenin phosphorylation and degradation, thus resulting in suppression of β-catenin-Tcf/Lef-mediated transactivation. When present in the nucleus, both uPAR and β-catenin were shown to mutually regulate each other's transcription. The trancription of Wnt target genes via Tcf/Lef transcription factors is blocked by binding of the repressor protein Groucho/AES. During active Wnt signaling, β-catenin enters the nucleus and displaces Groucho from Tcf/Lef and allows active complex formation for transcription of Wnt target genes. From our results, we observed that uPAR can also associate with repressor protein Groucho/AES and it is speculated that the role of uPAR in the nucleus could displace Groucho from Tcf/Lef or it is possible that the excess of uPAR is captured by the repressor protein Groucho/AES.
